AI -Generated Active Ingredients: Who Owns the Invention? - RÖDL
Those who do not adapt IP strategy and contract structures risk undermining the value of their own research. Rödl supports pharmaceutical and biotech ...
- Topics
- Healthcare
- Tracked via
- “AI Risks”